📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
23 announcements match the current filters (relevance ≥ 5).
Cyient DLM Q3 FY26 PAT at ₹112.3M; Revenue Declines 31.7% YoY to ₹3,033M
Cyient DLM reported a consolidated revenue of ₹3,033.47 million for Q3 FY26, marking a significant 31.7% decline compared to ₹4,442.36 million in the same quarter last year. While Net Profit remained relatively flat YoY at ₹112.33 million, it witnessed a sharp sequential drop from ₹321.45 million in Q2 FY26. The company is seeking shareholder approval to vary the objects of its IPO funds, of which ₹451.27 million remains unutilised. Additionally, the company recognized a ₹16 million expense due to the implementation of new national labour codes.
Key Highlights
Consolidated revenue for Q3 FY26 fell to ₹3,033.47 million from ₹4,442.36 million YoY.
Net profit for the quarter stood at ₹112.33 million, a marginal increase from ₹109.91 million YoY but down 65% QoQ.
Unutilised IPO proceeds as of December 31, 2025, stand at ₹451.27 million, with a proposal to vary fund objects.
Recognized a one-time provision of ₹16 million for defined benefit obligations following new Government labour codes.
9M FY26 consolidated revenue reached ₹8,924.08 million with a total net profit of ₹508.41 million.
👀 What to Watch
Investors should exercise caution due to the significant YoY revenue contraction and the sharp sequential decline in profitability. Monitor the upcoming shareholder vote regarding the change in IPO fund utilization for clues on the company's revised capital allocation strategy.
Cyient DLM Shareholders Approve Appointment of Four Independent Directors with High Majority
Cyient DLM Limited has successfully passed four special resolutions via postal ballot for the appointment and re-appointment of Independent Directors. Dr. Ganesh Natarajan and Mr. Giridhar Aramane were appointed as new Independent Directors, receiving 98.72% and 99.99% support respectively. Dr. Vanitha Datla and Mr. Jehangir Ardeshir were re-appointed for second terms, both securing approximately 89.6% of the votes. The high voter turnout of nearly 80% reflects strong institutional and promoter engagement in the company's governance.
Key Highlights
Appointment of Mr. Giridhar Aramane received near-unanimous approval with 99.99% votes in favor
Dr. Ganesh Natarajan's appointment as Independent Director approved with 98.72% majority
Re-appointments of Dr. Vanitha Datla and Mr. Jehangir Ardeshir passed with 89.60% and 89.61% support
Total voting turnout reached 79.90% of outstanding shares, involving 63.4 million votes
All resolutions were passed as Special Resolutions through a remote e-voting process ending January 11, 2026
👀 What to Watch
Investors should take confidence in the company's strengthened board and high level of shareholder participation. No immediate portfolio changes are required as these are positive governance-related developments.
Cyient DLM: Postal Ballot for Director Appointments & Re-appointments
Cyient DLM Limited is seeking shareholder approval via postal ballot for the appointment and re-appointment of several Independent Directors. Dr. Ganesh Natarajan is proposed as a Non-Executive Independent Director for 3 years starting October 14, 2025. Dr. Vanitha Datla and Mr. Jehangir Ardeshir are proposed for re-appointment as Independent Directors for a second term of five years commencing December 12, 2025. Mr. Giridhar Aramane is proposed as Non-Executive Independent Director for 3 years starting November 26, 2025. The e-voting period is from December 13, 2025, to January 11, 2026, with results announced by January 12, 2026.
Key Highlights
Appointment of Dr. Ganesh Natarajan (DIN:00176393) as Non-Executive, Independent Director effective 14 October, 2025 for 3 years.
Re-Appointment of Dr. Vanitha Datla (DIN: 00480422) as Non-Executive, Independent Director for a second term of five years commencing from 12 December 2025.
Re-Appointment of Mr. Jehangir Ardeshir (DIN: 02344835) as Non-Executive, Independent Director for a second term of five years commencing from 12 December 2025.
Appointment of Mr. Giridhar Aramane (DIN: 00483130) as Non-Executive, Independent Director effective 26 November, 2025 for 3 years.
Remote e-voting period: December 13, 2025 to January 11, 2026.
👀 What to Watch
Shareholders should review the Postal Ballot Notice and cast their votes electronically between December 13, 2025 and January 11, 2026. Pay attention to the profiles of the directors being appointed/re-appointed.
